BioMarin Pharmaceutical, Inc. (BMRN)
61.73
+0.62
(+1.01%)
USD |
NASDAQ |
Feb 27, 16:00
59.25
-2.48
(-4.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Research and Development Expense (TTM) : 700.97M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 135.84M |
| Gilead Sciences, Inc. | 5.688B |
| Merck & Co., Inc. | 12.71B |
| MannKind Corp. | 66.35M |
| AbbVie, Inc. | 9.096B |